Company profile · free preview

CME Group Inc.

CME · NASDAQ · Financial Services · Updated 10/25/2026

Revenue

$6.5B

Fiscal 2025

Net income

$4.1B

Fiscal 2025

Free cash flow

$4.2B

Fiscal 2025

Net cash / (debt)

—

Fiscal 2025

Five-year financials

Fiscal year20252024202320222021
Revenue$6.5B$6.1B$5.6B$5.0B$4.7B
Net income$4.1B$3.5B$3.2B$2.7B$2.6B
Diluted EPS—————
Operating cash flow$4.3B$3.7B$3.5B$3.1B$2.4B
Free cash flow$4.2B$3.6B$3.4B$3.0B$2.3B
Cash$4.4B$2.9B$2.9B$2.7B$2.8B
Total debt—————

Where the cash went

Cumulative, fiscal 2021–2025, straight from the reported cash-flow statements.

Reinvested in capex

2.8%

of operating cash flow

Returned to owners

—

of free cash flow (buybacks + dividends)

Diluted share count

—

change 2021–2025

Capital expenditure $470.8MBar width = share of $16.9B operating cash flow
Operating cash flow$16.9B
Capital expenditure($470.8M)
Free cash flow$16.4B
Share buybacks—
Dividends paid—
Acquisitions (net)—
Net debt issued / (repaid)—
Stock-based compensation (non-cash)—

"—" means a year didn't report that line, so no total is shown rather than an estimate.

SEC filings

  • 10-K · period 2025-12-312026-02-26EDGAR

Ask anything about CME Group Inc.'s filings

"What changed since last year?" "Where is the cash going?" Get answers drawn straight from the filings.

Start researching free

More companies